Evaluation of antioxidants systems in pituitary-adrenal axis diseases.

Antonio Mancini, Andrea Silvestrini, Alfredo Pontecorvi, Elisabetta Meucci, Erika Leone, Vincenzo Di Donna, Laura De Marinis Grasso, Roberto Festa, Gian Paolo Littarru

Research output: Contribution to journalArticle

9 Citations (Scopus)


The role of adrenal steroids in antioxidant regulation is not known. Previously, we demonstrated some Coenzyme Q(10) (CoQ(10)) alterations in pituitary diseases, which can induce complex pictures due to alterations of different endocrine axes. Therefore we determined CoQ(10) and Total Antioxidant Capacity (TAC) in pituitary-dependent adrenal diseases: 6 subjects with ACTH-dependent adrenal hyperplasia (AH); 19 with secondary isolated hypoadrenalism (IH), 19 with associated hypothyroidism (multiple pituitary deficiencies, MPH). CoQ(10) was assayed by HPLC; TAC by the system metmyoglobin-H(2)O(2), which, interacting with the chromogenous 2,2(I)-azinobis-(3-ethylbenzothiazoline-6-sulphonate), generates a spectroscopically revealed radical compound after a latency time (Lag) proportional to the antioxidant content. CoQ(10) levels were significantly lower in IH than AH and MPH, with a similar trend when adjusted for cholesterol. Also TAC was lower in IH than in AH and MPH, suggesting that adrenal hormones can influence antioxidants. However, since thyroid hormones modulate CoQ(10) levels and metabolism, when thyroid deficiency coexists it seems to play a prevalent influence.
Original languageEnglish
Pages (from-to)138-145
Number of pages8
Publication statusPublished - 2010


  • adrenal glands
  • coenzyme Q10
  • total antioxidant capacity


Dive into the research topics of 'Evaluation of antioxidants systems in pituitary-adrenal axis diseases.'. Together they form a unique fingerprint.

Cite this